Search results
Results from the WOW.Com Content Network
Because of the reduced toxicity, dose-adjusted patients were able to be treated for longer periods of time. [23] BSA-dosed people were treated for a total of 680 months while people in the dose-adjusted group were treated for a total of 791 months. [23] Completing the course of treatment is an important factor in achieving better treatment ...
Cancer immunotherapy (immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight the disease. [1] It is an application of the fundamental research of cancer immunology (immuno-oncology) and a growing subspecialty of oncology.
Immunotherapy or biological therapy is the treatment of disease by activating or suppressing the immune system.Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies.
The Pfizer study used conventional response criteria, and an early interim analysis found no survival advantage for the treated patients, leading to the termination of the trial in April 2008. [ 7 ] [ 8 ] However within a year of this development, Pfizer's investigators were beginning to notice a separation of survival curves between treatment ...
Cancer immunology (immuno-oncology) is an interdisciplinary branch of biology and a sub-discipline of immunology that is concerned with understanding the role of the immune system in the progression and development of cancer; the most well known application is cancer immunotherapy, which utilises the immune system as a treatment for cancer.
While not directly harmful to the patient, [15] the response destroyed the virus thus preventing it from destroying the cancer. [17] Early efforts also found that only certain cancers could be treated through virotherapy. [18] Even when a response was seen, these responses were neither complete nor durable. [15]
Doctors discovered he had a rare cancer in his sinuses and mouth that required several treatments. Man, 27, had what doctors thought were recurring sinus infections — it was a rare cancer Skip ...
Oral and pharyngeal mucositis and esophagitis suggest Herpes simplex infection or candidiasis. Either empirical antiviral or antifungal therapy or both should be considered. In addition to infections due to neutropenia, a patient with the Acute Radiation Syndrome will also be at risk for viral, fungal and parasitic infections. If these types of ...